InTest Finally Gets the Turn It Promised — and the Tape Shrugs
Record $49.4M orders and a $59.7M backlog point squarely at 2027, but a flat Q4 guide, negative free cash flow, and a 17% slide from the October high say the market wants proof first.
INTT · Earnings Call · 2026-11-06
The turn arrives — six quarters after the warning
For the better part of two years, InTest's calls read like a weather report from a drought. In November 2025, Duncan Gilmour described front-end semi as “anemic still” — Duncan Gilmour, Chief Financial Officer and Treasurer · 2025-11-05. In February 2026 he was blunter about the back half: “We have not seen the turn yet.” — Duncan Gilmour, Chief Financial Officer and Treasurer · 2026-02-27 By August, Rich Rogoff was planning for the cycle in nine-to-twelve-month increments. Then Thursday's Q3 print delivered the thing itself: “The semiconductor demand we told you to expect arrived in the third quarter.” — Richard Rogoff, President and Chief Executive Officer · 2026-11-06
Arrived how? Total orders hit a record $49.4 million — 41% above the quarter's revenue, up 31% year over year. Inside that, back-end semi orders were $23.9 million, nearly four times the year-ago level, and total Semi orders of $25.1 million accounted for roughly half the book. The mechanism is the good kind of cyclical: “the constraint has moved from building wafers to packaging and testing finished devices fast enough” — Richard Rogoff, President and Chief Executive Officer · 2026-11-06 — and every tester a customer bolts down needs a manipulator, docking hardware and an interface, which is InTest's lane. Non-semi orders of $24.3 million rose 44% sequentially, led by Auto/EV more than doubling off a soft Q2 and Defense/Aerospace up 43%, with Induction Heating orders rising for a second straight quarter.
Revenue was $35.1 million, up 34% from $26.2 million — the third consecutive quarter above 25% growth — and gross margin of 47.7% beat guidance by a wide margin (up 580bp year over year) on favorable mix. Adjusted EBITDA of $4.4 million was a 12.6% margin, versus 0.4 million and a rounding error a year ago.
The guide that doesn't match the headline
Here is where the story gets less tidy. Q4 guidance is $34–36 million in revenue with gross margin of roughly 45%. The midpoint is essentially flat sequentially, and margins are guided down more than two points from Q3's mix-inflated 47.7%. The record orders are not a Q4 event; they are a 2027 event. Roughly 60% of the $59.7 million backlog — itself up 32% since June — is scheduled to ship next year, and management says the Q3 semi orders convert “largely in the first half” — Duncan Gilmour, Chief Financial Officer and Treasurer · 2026-11-06 of 2027.
Max Michaelis of Lake Street asked the obvious question: is this pull-forward? Rogoff's answer was honest but evasive — “it's hard to tell what the market is going to do, but we do see strength in Semi for sure, seemingly to go into the early part of 2027, at least.” — Richard Rogoff, President and Chief Executive Officer · 2026-11-06 Customers are ordering further ahead because testers carry 18-month lead times, which gives visibility but also means an order today is a bet on capacity in 2027, not demand this winter. The tape has already made its call on that bet: the stock peaked at $16.10 on October 28 — three weeks after the October 5 order preannouncement — and has since given back 17%, closing the 90-day window down 14.8%. Full-cycle, shares remain 50% below the June 2023 high of $26.91.
Demand has arrived. It is in our expanding backlog, and we are executing on our operational plan to convert it consistently.
The pivot nobody has priced yet: from roll-up to platform
Rogoff is nine months into the job and clearly wants a different identity for a company that grew by acquisition and, in his words, ran its businesses "largely separately." The operational plan he previewed in Q2 is now a formal program examined through five lenses — portfolio, product cost and mix, operating-expense deployment, manufacturing footprint, and shared R&D. Scott Taylor joined October 1 as VP/GM of ITS to execute it, and full-year 2027 guidance comes with Q4 results.
This is a genuine change in vocabulary. The prior six quarters were peppered with restructuring charges, headcount reduction, cost actions and austerity measures — defensive, quarter-by-quarter cost surgery. The new language is coordinated platform and commercial opportunities, which is an offensive claim. The proof will be in the margins: the fundamentals file shows gross margin at 40.5% in the June quarter, down from a 52.9% peak in 2017, precisely the dilution that a mix shift back toward back-end semi is supposed to cure.
What management stopped talking about
The quiet omissions are as informative as the headlines. Life Sciences was the diversification hero — Rogoff's predecessor called it “a bright spot for sure” — Nick Grant, President and Chief Executive Officer · 2026-02-27 in February — yet in Q3 it declined $0.8 million sequentially and appears in the keyword set only as declines in Life Sciences. Safety/Security also fell. The diversification story has quietly rotated: Defense/Aerospace more than tripled year over year and now carries the narrative, with the company selling through prime contractors across induction heating, flying-probe PCB test and process chillers.
Front-end semi, the great 2026 hope, has been de-risked into irrelevance for now. Rogoff's guardrail — “I don't think it's going to come back to what it did 3 or 4 years ago” — Richard Rogoff, President and Chief Executive Officer · 2026-11-06 — is a long way from February's enthusiasm about silicon-carbide and gallium-nitride positioning.
And then there is cash. A record-order quarter produced negative $0.6 million of free cash flow, as receivables swelled $3.6 million and customer deposits fell $1 million. Receivables now sit at 76.1% of revenue, close to the 2025 high of 85.6%. Gilmour waved off the lead times question with “nothing out of the ordinary” — Duncan Gilmour, Chief Financial Officer and Treasurer · 2026-11-06, but he also conceded "a little bit more investment in working capital and inventory." The balance sheet can carry it — $16 million of effective net cash and $61 million of total liquidity, 0.5x trailing leverage — though a fresh S-3 shelf filed the same afternoon is a reminder that small-cap growth is rarely self-funded.
The lane less crowded
One reason to take the order book seriously: InTest is not selling into the trade the market just punished. Over the last 90 days the tape has savaged the AI data center complex — co-packaged optics, HBM, gig-per-lane interconnect all down 30–50% — while InTest's demand is mixed-signal, analog, high-power conversion and communications devices, where high power thermal management is the binding constraint. Memory tightness, the theme Rogoff flagged in August as a driver of “increased capacity needs” — Richard Rogoff, President and Chief Executive Officer · 2026-08-10, is now a cross-market refrain among semiconductor reporters this week. InTest is a second-derivative play on that, wearing a semiconductor multiple of 1.8x sales rather than an AI one.
The bull case writes itself: a $171 million market cap with a $59.7 million backlog, 41% book-to-bill, and a self-help plan landing just as its highest-margin product line inflects. The bear case is equally legible: the orders are for 2027, Q4 is flat, cash is going backwards, and the market has already stopped paying up. What the next two quarters decide is whether "demand has arrived" becomes a durable cycle or a single quarter of customers buying 18 months early.